Annual EBIT:
-$201.14M-$29.19M(-16.98%)Summary
- As of today, CNTA annual earnings before interest & taxes is -$201.14 million, with the most recent change of -$29.19 million (-16.98%) on December 31, 2024.
- During the last 3 years, CNTA annual EBIT has fallen by -$61.83 million (-44.38%).
- CNTA annual EBIT is now -6258.34% below its all-time high of -$3.16 million, reached on December 31, 2020.
Performance
CNTA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$53.47M+$1.83M(+3.31%)Summary
- As of today, CNTA quarterly earnings before interest & taxes is -$53.47 million, with the most recent change of +$1.83 million (+3.31%) on September 30, 2025.
- Over the past year, CNTA quarterly EBIT has dropped by -$6.59 million (-14.05%).
- CNTA quarterly EBIT is now -284.88% below its all-time high of $28.92 million, reached on December 1, 2020.
Performance
CNTA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$213.55M-$6.59M(-3.18%)Summary
- As of today, CNTA TTM earnings before interest & taxes is -$213.55 million, with the most recent change of -$6.59 million (-3.18%) on September 30, 2025.
- Over the past year, CNTA TTM EBIT has dropped by -$51.09 million (-31.45%).
- CNTA TTM EBIT is now -838.42% below its all-time high of $28.92 million, reached on December 1, 2020.
Performance
CNTA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CNTA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -17.0% | -14.1% | -31.4% |
| 3Y3 Years | -44.4% | -10.0% | +3.8% |
| 5Y5 Years | -3969.2% | -284.9% | -838.4% |
CNTA EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -44.4% | +4.3% | -73.1% | +27.6% | -37.3% | +3.8% |
| 5Y | 5-Year | -6258.3% | +4.3% | -284.9% | +27.6% | -838.4% | +3.8% |
| All-Time | All-Time | -6258.3% | +4.3% | -284.9% | +27.6% | -838.4% | +3.8% |
CNTA EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$53.47M(+3.3%) | -$213.55M(-3.2%) |
| Jun 2025 | - | -$55.30M(-79.0%) | -$206.96M(-5.8%) |
| Mar 2025 | - | -$30.90M(+58.2%) | -$195.69M(+2.6%) |
| Dec 2024 | -$201.14M(-17.0%) | -$73.89M(-57.6%) | -$200.87M(-23.6%) |
| Sep 2024 | - | -$46.88M(-6.5%) | -$162.46M(-4.4%) |
| Jun 2024 | - | -$44.03M(-22.1%) | -$155.56M(+2.0%) |
| Mar 2024 | - | -$36.07M(-1.6%) | -$158.70M(+7.7%) |
| Dec 2023 | -$171.95M(+18.2%) | -$35.48M(+11.2%) | -$171.95M(+3.6%) |
| Sep 2023 | - | -$39.98M(+15.3%) | -$178.38M(+4.6%) |
| Jun 2023 | - | -$47.17M(+4.4%) | -$187.02M(+9.9%) |
| Mar 2023 | - | -$49.32M(-17.7%) | -$207.66M(+0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$210.15M(-50.8%) | -$41.91M(+13.8%) | -$209.29M(+5.7%) |
| Sep 2022 | - | -$48.61M(+28.3%) | -$222.02M(-4.9%) |
| Jun 2022 | - | -$67.82M(-33.1%) | -$211.56M(-21.8%) |
| Mar 2022 | - | -$50.94M(+6.8%) | -$173.65M(-22.5%) |
| Dec 2021 | -$139.31M(-4303.9%) | -$54.65M(-43.3%) | -$141.73M(-143.7%) |
| Sep 2021 | - | -$38.14M(-27.5%) | -$58.16M(-190.5%) |
| Jun 2021 | - | -$29.92M(-57.3%) | -$20.02M(-302.2%) |
| Mar 2021 | - | -$19.02M(-165.8%) | $9.90M(-65.8%) |
| Dec 2020 | -$3.16M(+36.0%) | - | - |
| Dec 2020 | - | $28.92M | $28.92M |
| Dec 2019 | -$4.94M | - | - |
FAQ
- What is Centessa Pharmaceuticals plc annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc annual EBIT year-on-year change?
- What is Centessa Pharmaceuticals plc quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc quarterly EBIT year-on-year change?
- What is Centessa Pharmaceuticals plc TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc TTM EBIT year-on-year change?
What is Centessa Pharmaceuticals plc annual earnings before interest & taxes?
The current annual EBIT of CNTA is -$201.14M
What is the all-time high annual EBIT for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high annual earnings before interest & taxes is -$3.16M
What is Centessa Pharmaceuticals plc annual EBIT year-on-year change?
Over the past year, CNTA annual earnings before interest & taxes has changed by -$29.19M (-16.98%)
What is Centessa Pharmaceuticals plc quarterly earnings before interest & taxes?
The current quarterly EBIT of CNTA is -$53.47M
What is the all-time high quarterly EBIT for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high quarterly earnings before interest & taxes is $28.92M
What is Centessa Pharmaceuticals plc quarterly EBIT year-on-year change?
Over the past year, CNTA quarterly earnings before interest & taxes has changed by -$6.59M (-14.05%)
What is Centessa Pharmaceuticals plc TTM earnings before interest & taxes?
The current TTM EBIT of CNTA is -$213.55M
What is the all-time high TTM EBIT for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high TTM earnings before interest & taxes is $28.92M
What is Centessa Pharmaceuticals plc TTM EBIT year-on-year change?
Over the past year, CNTA TTM earnings before interest & taxes has changed by -$51.09M (-31.45%)